These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30150748)

  • 1. Revealing the mechanisms of membrane protein export by virulence-associated bacterial secretion systems.
    Krampen L; Malmsheimer S; Grin I; Trunk T; Lührmann A; de Gier JW; Wagner S
    Nat Commun; 2018 Aug; 9(1):3467. PubMed ID: 30150748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of bacterial secretion systems and effector proteins - insights into Aeromonas pathogenicity mechanisms.
    Matys J; Turska-Szewczuk A; Sroka-Bartnicka A
    Acta Biochim Pol; 2020 Aug; 67(3):283-293. PubMed ID: 32865955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifunctional region of the Shigella type 3 effector IpgB1 is important for secretion from bacteria and membrane targeting in eukaryotic cells.
    Costa SC; Lesser CF
    PLoS One; 2014; 9(4):e93461. PubMed ID: 24718571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of the bacterial type III secretion machinery.
    Diepold A; Wagner S
    FEMS Microbiol Rev; 2014 Jul; 38(4):802-22. PubMed ID: 24484471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substrate specificity switch FlhB assembles onto the export gate to regulate type three secretion.
    Kuhlen L; Johnson S; Zeitler A; Bäurle S; Deme JC; Caesar JJE; Debo R; Fisher J; Wagner S; Lea SM
    Nat Commun; 2020 Mar; 11(1):1296. PubMed ID: 32157081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Third Transmembrane Domain of EscR Is Critical for Function of the Enteropathogenic
    Tseytin I; Madar A; Mitrovic B; Deng W; Finlay BB; Sal-Man N
    mSphere; 2018 Jul; 3(4):. PubMed ID: 30045964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Targeting Factors Are Required for LXG Toxin Export by the Bacterial Type VIIb Secretion System.
    Klein TA; Grebenc DW; Shah PY; McArthur OD; Dickson BH; Surette MG; Kim Y; Whitney JC
    mBio; 2022 Oct; 13(5):e0213722. PubMed ID: 36036513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence.
    Harding CM; Kinsella RL; Palmer LD; Skaar EP; Feldman MF
    PLoS Pathog; 2016 Jan; 12(1):e1005391. PubMed ID: 26764912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chaperone binding domain of SopE inhibits transport via flagellar and SPI-1 TTSS in the absence of InvB.
    Ehrbar K; Winnen B; Hardt WD
    Mol Microbiol; 2006 Jan; 59(1):248-64. PubMed ID: 16359332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III secretion: a secretory pathway serving both motility and virulence (review).
    Journet L; Hughes KT; Cornelis GR
    Mol Membr Biol; 2005; 22(1-2):41-50. PubMed ID: 16092523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane substrates of type three secretion system injectisomes.
    Godlee C; Holden DW
    Microbiology (Reading); 2023 Jan; 169(1):. PubMed ID: 36748571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A translocator-specific export signal establishes the translocator-effector secretion hierarchy that is important for type III secretion system function.
    Tomalka AG; Stopford CM; Lee PC; Rietsch A
    Mol Microbiol; 2012 Dec; 86(6):1464-81. PubMed ID: 23121689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion.
    Stebbins CE; Galán JE
    Nature; 2001 Nov; 414(6859):77-81. PubMed ID: 11689946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bacterial toxin-antitoxin module is the origin of inter-bacterial and inter-kingdom effectors of Bartonella.
    Harms A; Liesch M; Körner J; Québatte M; Engel P; Dehio C
    PLoS Genet; 2017 Oct; 13(10):e1007077. PubMed ID: 29073136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems.
    Blasey N; Rehrmann D; Riebisch AK; Mühlen S
    Front Cell Infect Microbiol; 2022; 12():1065561. PubMed ID: 36704108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and delivery of effector proteins into eukaryotic cells by bacterial secretion systems.
    Cambronne ED; Roy CR
    Traffic; 2006 Aug; 7(8):929-39. PubMed ID: 16734660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III secretion system translocator has a molten globule conformation both in its free and chaperone-bound forms.
    Faudry E; Job V; Dessen A; Attree I; Forge V
    FEBS J; 2007 Jul; 274(14):3601-3610. PubMed ID: 17578515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-Injection Machines in Bacteria.
    Galán JE; Waksman G
    Cell; 2018 Mar; 172(6):1306-1318. PubMed ID: 29522749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
    Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
    BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Vibrio parahaemolyticus type III secretion system 2-associated chaperone VocC for the T3SS2-specific effector VopC.
    Akeda Y; Kodama T; Saito K; Iida T; Oishi K; Honda T
    FEMS Microbiol Lett; 2011 Nov; 324(2):156-64. PubMed ID: 22092817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.